Genetic mapping and predictive modeling of paralog synthetic lethality

Michael J Flister1, Daniel Verduzco1, Sakina Petiwala1

  • 1AbbVie Inc., 1 North Waukegan Road, North Chicago, IL 60064, USA.

Cell Reports
|November 8, 2025
PubMed
Summary

Synthetic lethality, a potential cancer treatment, is infrequent and varies between tumors. This study identified key features of protein interactions that predict and explain this variability in paralog synthetic lethality.